| Q2 2024 |
86 |
$635M |
+$171M |
-$91.2M |
+$79.5M |
XENE, APGE, MDGL, ACLX, TEVA
|
13F-HR |
8/14/2024, 04:06 PM |
| Q1 2024 |
74 |
$601M |
+$225M |
-$206M |
+$18.7M |
APGE, XENE, MDGL, CRNX, AUTL
|
13F-HR |
5/14/2024, 04:30 PM |
| Q4 2023 |
82 |
$548M |
+$170M |
-$77.9M |
+$92.3M |
IMGN, CERE, CBAY, MDGL, XENE
|
13F-HR |
2/13/2024, 04:52 PM |
| Q3 2023 |
104 |
$356M |
+$179M |
-$85.3M |
+$93.7M |
APGE, TEVA, CBAY, CERE, ACLX
|
13F-HR |
11/14/2023, 03:58 PM |
| Q2 2023 |
98 |
$286M |
+$116M |
-$157M |
-$41.2M |
MDGL, CERE, ESTA, KDNY, MDGL
|
Restatement |
8/21/2023, 05:07 PM |
| Q1 2023 |
74 |
$303M |
+$128M |
-$35.2M |
+$92.6M |
KDNY, MDGL, SPY, RXDX, MRK
|
13F-HR |
5/15/2023, 04:08 PM |
| Q4 2022 |
61 |
$255M |
+$96.5M |
-$43.1M |
+$53.4M |
KDNY, MDGL, BMY, ESTA, ASND
|
13F-HR |
2/13/2023, 03:04 PM |
| Q3 2022 |
62 |
$358M |
+$210M |
-$23.9M |
+$186M |
SPY, ESTA, KDNY, GBT, IWM
|
13F-HR |
11/14/2022, 03:28 PM |
| Q2 2022 |
52 |
$237M |
+$80.8M |
-$24.3M |
+$56.5M |
ESTA, KURA, KDNY, NARI, ASND
|
13F-HR |
8/12/2022, 04:22 PM |
| Q1 2022 |
58 |
$625M |
+$482M |
-$21.7M |
+$460M |
SPY, NARI, MORF, KURA, ASND
|
13F-HR |
5/13/2022, 04:33 PM |
| Q4 2021 |
54 |
$275M |
+$124M |
-$16.2M |
+$108M |
MORF, SWTX, SAVA, VINC, NARI
|
13F-HR |
2/11/2022, 03:11 PM |
| Q3 2021 |
66 |
$251M |
+$86.8M |
-$36.2M |
+$50.6M |
BBIO, VINC, MORF, NARI, KURA
|
13F-HR |
11/12/2021, 04:35 PM |
| Q2 2021 |
62 |
$210M |
+$59M |
-$43.8M |
+$15.2M |
BBIO, MORF, VINC, NAUT, KURA
|
13F-HR |
8/13/2021, 04:43 PM |
| Q1 2021 |
62 |
$204M |
+$105M |
-$63.6M |
+$41.4M |
BBIO, MORF, CRIS, VINC, KURA
|
13F-HR |
5/14/2021, 10:57 AM |
| Q4 2020 |
61 |
$188M |
|
|
|
EIDX, SPY, CRIS, BBIO, KURA
|
13F-HR |
2/12/2021, 01:04 PM |